CPHI - China Pharma Holdings Inc.
(NaN%)
Sell
Gross Profit is Negative
7%
based on last 5 year data.
Income Statement is WEAK
Revenue Growth is -33.1%
Operating Income is Negative
Net Income is Negative
Earnings Per Share (EPS) is Negative but improving
Net Margin is -106.3%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 0.56
Debt Ratio is 0.51
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.08
Cash Flow
Cash from Operations Growth is -86.28%
Capital Expenditure not available
Net Increase in Cash is Negative
Long Term Score Trend is NEUTRAL
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
China Pharma Holdings Inc. (CPHI) - www.chinapharmaholdings.com
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company’s wholly-owned subsidiary, Hainan Helpson Medical & Biotechnique Co., Ltd., is located in Haikou City, Hainan Province.Exchange - NYSE MKT LLC
Industry - Pharmaceutical Preparation Manufacturing
Sector - Manufacturing
CEO - Zhilin Li
Employees - 236
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.
Know the Stock © 2025 and future.